Annual CFO
-$3.12 B
-$8.10 B-162.60%
31 December 2023
Summary:
Moderna annual cash flow from operations is currently -$3.12 billion, with the most recent change of -$8.10 billion (-162.60%) on 31 December 2023. During the last 3 years, it has fallen by -$5.14 billion (-253.82%). MRNA annual CFO is now -122.89% below its all-time high of $13.62 billion, reached on 31 December 2021.MRNA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$1.57 B
-$292.00 M-22.92%
30 September 2024
Summary:
Moderna quarterly cash flow from operations is currently -$1.57 billion, with the most recent change of -$292.00 million (-22.92%) on 30 September 2024. Over the past year, it has increased by +$34.00 million (+2.12%). MRNA quarterly CFO is now -138.54% below its all-time high of $4.06 billion, reached on 30 June 2021.MRNA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$3.21 B
+$34.00 M+1.05%
30 September 2024
Summary:
Moderna TTM cash flow from operations is currently -$3.21 billion, with the most recent change of +$34.00 million (+1.05%) on 30 September 2024. Over the past year, it has dropped by -$1.13 billion (-54.33%). MRNA TTM CFO is now -123.55% below its all-time high of $13.62 billion, reached on 31 December 2021.MRNA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -162.6% | +2.1% | -54.3% |
| 3 y3 years | -253.8% | -147.8% | -127.7% |
| 5 y5 years | -842.4% | -1362.3% | -611.1% |
MRNA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -122.9% | at low | -147.3% | +2.1% | -123.5% | +1.1% |
| 5 y | 5 years | -122.9% | at low | -138.5% | +2.1% | -123.5% | +1.1% |
| alltime | all time | -122.9% | at low | -138.5% | +2.1% | -123.5% | +1.1% |
Moderna Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.57 B(+22.9%) | -$3.21 B(-1.0%) |
| June 2024 | - | -$1.27 B(+28.8%) | -$3.24 B(+12.5%) |
| Mar 2024 | - | -$989.00 M(-259.0%) | -$2.88 B(-7.6%) |
| Dec 2023 | -$3.12 B(-162.6%) | $622.00 M(-138.9%) | -$3.12 B(+50.0%) |
| Sept 2023 | - | -$1.60 B(+74.9%) | -$2.08 B(+819.5%) |
| June 2023 | - | -$915.00 M(-25.3%) | -$226.00 M(-122.8%) |
| Mar 2023 | - | -$1.23 B(-173.7%) | $993.00 M(-80.1%) |
| Dec 2022 | $4.98 B(-63.4%) | $1.66 B(+559.5%) | $4.98 B(-24.9%) |
| Sept 2022 | - | $252.00 M(-17.1%) | $6.63 B(-31.3%) |
| June 2022 | - | $304.00 M(-89.0%) | $9.65 B(-28.0%) |
| Mar 2022 | - | $2.76 B(-16.5%) | $13.41 B(-1.5%) |
| Dec 2021 | $13.62 B(+571.9%) | $3.31 B(+1.0%) | $13.62 B(+17.7%) |
| Sept 2021 | - | $3.28 B(-19.4%) | $11.57 B(+25.9%) |
| June 2021 | - | $4.06 B(+36.8%) | $9.19 B(+80.1%) |
| Mar 2021 | - | $2.97 B(+135.0%) | $5.10 B(+151.8%) |
| Dec 2020 | $2.03 B(-541.6%) | $1.26 B(+41.5%) | $2.03 B(+205.3%) |
| Sept 2020 | - | $893.00 M(-3820.8%) | $663.95 M(-297.5%) |
| June 2020 | - | -$24.00 M(-77.4%) | -$336.15 M(-20.1%) |
| Mar 2020 | - | -$106.00 M(+7.0%) | -$420.73 M(-8.3%) |
| Dec 2019 | -$459.00 M(+38.7%) | -$99.05 M(-7.5%) | -$459.00 M(+1.8%) |
| Sept 2019 | - | -$107.09 M(-1.4%) | -$450.97 M(+6.3%) |
| June 2019 | - | -$108.58 M(-24.7%) | -$424.08 M(+16.6%) |
| Mar 2019 | - | -$144.27 M(+58.5%) | -$363.75 M(+9.9%) |
| Dec 2018 | -$330.87 M(-0.2%) | -$91.02 M(+13.5%) | -$330.87 M(+37.8%) |
| Sept 2018 | - | -$80.21 M(+66.2%) | -$240.18 M(+50.0%) |
| June 2018 | - | -$48.25 M(-56.7%) | -$160.16 M(+42.6%) |
| Mar 2018 | - | -$111.39 M(>+9900.0%) | -$112.28 M(+8806.3%) |
| Dec 2017 | -$331.48 M(-596.7%) | -$337.50 K(+77.0%) | -$1.26 M(+9.7%) |
| Sept 2017 | - | -$190.70 K(-48.2%) | -$1.15 M(+15.5%) |
| June 2017 | - | -$368.50 K(+1.2%) | -$995.30 K(+40.9%) |
| Mar 2017 | - | -$364.00 K(+60.9%) | -$706.50 K(+35.2%) |
| Dec 2016 | $66.73 M(-3182.4%) | - | - |
| Dec 2016 | - | -$226.20 K(+518.0%) | -$522.40 K(-38.8%) |
| Sept 2016 | - | -$36.60 K(-54.1%) | -$854.20 K(-35.6%) |
| June 2016 | - | -$79.70 K(-55.7%) | -$1.33 M(-21.2%) |
| Mar 2016 | - | -$179.90 K(-67.8%) | -$1.68 M(-22.3%) |
| Dec 2015 | -$2.17 M(-54.7%) | -$558.00 K(+9.8%) | -$2.17 M(-28.0%) |
| Sept 2015 | - | -$508.00 K(+16.2%) | -$3.01 M(-16.7%) |
| June 2015 | - | -$437.00 K(-34.0%) | -$3.61 M(-17.5%) |
| Mar 2015 | - | -$662.00 K(-52.8%) | -$4.38 M(-8.4%) |
| Dec 2014 | -$4.78 M(-1776.8%) | -$1.40 M(+26.2%) | -$4.78 M(+63.8%) |
| Sept 2014 | - | -$1.11 M(-7.5%) | -$2.92 M(+85.4%) |
| June 2014 | - | -$1.20 M(+12.8%) | -$1.57 M(+451.9%) |
| Mar 2014 | - | -$1.06 M(-331.5%) | -$285.00 K(-200.0%) |
| Dec 2013 | $285.00 K(-106.5%) | $460.00 K(+97.4%) | $285.00 K(-133.9%) |
| Sept 2013 | - | $233.00 K(+167.8%) | -$840.00 K(-36.7%) |
| June 2013 | - | $87.00 K(-117.6%) | -$1.33 M(-22.4%) |
| Mar 2013 | - | -$495.00 K(-25.6%) | -$1.71 M(-61.1%) |
| Dec 2012 | -$4.39 M(-72.8%) | -$665.00 K(+162.8%) | -$4.39 M(-22.3%) |
| Sept 2012 | - | -$253.00 K(-14.2%) | -$5.65 M(-44.4%) |
| June 2012 | - | -$295.00 K(-90.7%) | -$10.16 M(-31.3%) |
| Mar 2012 | - | -$3.18 M(+65.3%) | -$14.79 M(-8.3%) |
| Dec 2011 | -$16.12 M(-4.1%) | -$1.92 M(-59.7%) | -$16.12 M(-5.3%) |
| Sept 2011 | - | -$4.76 M(-3.2%) | -$17.02 M(-1.5%) |
| June 2011 | - | -$4.92 M(+9.1%) | -$17.29 M(+2.3%) |
| Mar 2011 | - | -$4.51 M(+59.4%) | -$16.90 M(+0.6%) |
| Dec 2010 | -$16.80 M(+123.3%) | -$2.83 M(-43.8%) | -$16.80 M(-5.1%) |
| Sept 2010 | - | -$5.03 M(+11.1%) | -$17.70 M(+1.7%) |
| June 2010 | - | -$4.53 M(+2.7%) | -$17.40 M(-9.0%) |
| Mar 2010 | - | -$4.41 M(+18.3%) | -$19.12 M(+154.0%) |
| Dec 2009 | -$7.53 M | -$3.73 M(-21.3%) | -$7.53 M(-23.7%) |
| Sept 2009 | - | -$4.74 M(-24.1%) | -$9.87 M(-23.5%) |
| June 2009 | - | -$6.24 M(-186.9%) | -$12.91 M(-24.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | $7.18 M(-218.3%) | -$17.13 M(-57.7%) |
| Dec 2008 | -$40.47 M(-12.9%) | -$6.07 M(-21.9%) | -$40.47 M(-17.8%) |
| Sept 2008 | - | -$7.78 M(-25.7%) | -$49.25 M(-8.0%) |
| June 2008 | - | -$10.47 M(-35.2%) | -$53.51 M(-0.1%) |
| Mar 2008 | - | -$16.16 M(+8.9%) | -$53.57 M(+15.3%) |
| Dec 2007 | -$46.46 M(+214.9%) | -$14.84 M(+23.3%) | -$46.46 M(+21.0%) |
| Sept 2007 | - | -$12.04 M(+14.3%) | -$38.39 M(+14.8%) |
| June 2007 | - | -$10.53 M(+16.3%) | -$33.45 M(+65.7%) |
| Mar 2007 | - | -$9.05 M(+33.6%) | -$20.18 M(+36.8%) |
| Dec 2006 | -$14.75 M(-52.8%) | -$6.78 M(-4.5%) | -$14.75 M(-7.1%) |
| Sept 2006 | - | -$7.09 M(-359.2%) | -$15.89 M(-14.2%) |
| June 2006 | - | $2.74 M(-175.6%) | -$18.52 M(-35.3%) |
| Mar 2006 | - | -$3.62 M(-54.2%) | -$28.61 M(-8.5%) |
| Dec 2005 | -$31.28 M(+63.2%) | -$7.91 M(-18.6%) | -$31.28 M(+42.1%) |
| Sept 2005 | - | -$9.72 M(+32.3%) | -$22.02 M(+18.7%) |
| June 2005 | - | -$7.35 M(+16.7%) | -$18.55 M(+6.3%) |
| Mar 2005 | - | -$6.30 M(-565.3%) | -$17.46 M(-8.9%) |
| Dec 2004 | -$19.17 M(+149.4%) | $1.35 M(-121.6%) | -$19.17 M(-28.3%) |
| Sept 2004 | - | -$6.26 M(+0.1%) | -$26.71 M(+1.1%) |
| June 2004 | - | -$6.26 M(-21.8%) | -$26.42 M(+7.0%) |
| Mar 2004 | - | -$8.01 M(+29.2%) | -$24.70 M(+221.3%) |
| Dec 2003 | -$7.69 M(+18.2%) | -$6.19 M(+3.8%) | -$7.69 M(+24.1%) |
| Sept 2003 | - | -$5.97 M(+31.7%) | -$6.19 M(+108.9%) |
| June 2003 | - | -$4.53 M(-150.3%) | -$2.96 M(-206.9%) |
| Mar 2003 | - | $9.01 M(-291.6%) | $2.77 M(-142.7%) |
| Dec 2002 | -$6.50 M(-11.7%) | -$4.70 M(+71.7%) | -$6.50 M(+31.1%) |
| Sept 2002 | - | -$2.74 M(-326.7%) | -$4.96 M(+64.8%) |
| June 2002 | - | $1.21 M(-545.8%) | -$3.01 M(-50.7%) |
| Mar 2002 | - | -$271.00 K(-91.4%) | -$6.11 M(-17.1%) |
| Dec 2001 | -$7.37 M(-6.3%) | -$3.16 M(+300.3%) | -$7.37 M(+27.0%) |
| Sept 2001 | - | -$789.00 K(-58.3%) | -$5.80 M(-14.9%) |
| June 2001 | - | -$1.89 M(+23.7%) | -$6.81 M(+16.9%) |
| Mar 2001 | - | -$1.53 M(-3.8%) | -$5.83 M(-25.9%) |
| Dec 2000 | -$7.86 M(+48.3%) | -$1.59 M(-11.8%) | -$7.86 M(-3.8%) |
| Sept 2000 | - | -$1.80 M(+99.1%) | -$8.17 M(+10.9%) |
| June 2000 | - | -$905.00 K(-74.6%) | -$7.37 M(-6.3%) |
| Mar 2000 | - | -$3.56 M(+87.6%) | -$7.87 M(+48.4%) |
| Dec 1999 | -$5.30 M(+103.8%) | -$1.90 M(+90.0%) | -$5.30 M(+29.3%) |
| Sept 1999 | - | -$1.00 M(-28.6%) | -$4.10 M(+32.3%) |
| June 1999 | - | -$1.40 M(+40.0%) | -$3.10 M(+55.0%) |
| Mar 1999 | - | -$1.00 M(+42.9%) | -$2.00 M(-23.1%) |
| Dec 1998 | -$2.60 M(-18.8%) | -$700.00 K(<-9900.0%) | -$2.60 M(-3.7%) |
| Sept 1998 | - | $0.00(-100.0%) | -$2.70 M(-28.9%) |
| June 1998 | - | -$300.00 K(-81.3%) | -$3.80 M(-13.6%) |
| Mar 1998 | - | -$1.60 M(+100.0%) | -$4.40 M(+37.5%) |
| Dec 1997 | -$3.20 M(+540.0%) | -$800.00 K(-27.3%) | -$3.20 M(+33.3%) |
| Sept 1997 | - | -$1.10 M(+22.2%) | -$2.40 M(+33.3%) |
| June 1997 | - | -$900.00 K(+125.0%) | -$1.80 M(+200.0%) |
| Mar 1997 | - | -$400.00 K(-20.0%) | -$600.00 K(+20.0%) |
| Dec 1996 | -$500.00 K(-600.0%) | - | - |
| Sept 1996 | - | -$500.00 K(-266.7%) | -$500.00 K(-600.0%) |
| June 1996 | $100.00 K(0.0%) | $300.00 K(-400.0%) | $100.00 K(-150.0%) |
| Mar 1996 | - | -$100.00 K(-50.0%) | -$200.00 K(+100.0%) |
| Dec 1995 | - | -$200.00 K(-300.0%) | -$100.00 K(-200.0%) |
| Sept 1995 | - | $100.00 K(>+9900.0%) | $100.00 K(0.0%) |
| June 1995 | $100.00 K(0.0%) | $0.00(0.0%) | $100.00 K(0.0%) |
| Mar 1995 | - | $0.00(0.0%) | $100.00 K(-200.0%) |
| Dec 1994 | - | $0.00(-100.0%) | -$100.00 K(-200.0%) |
| Sept 1994 | - | $100.00 K(>+9900.0%) | $100.00 K(0.0%) |
| June 1994 | $100.00 K | $0.00(-100.0%) | $100.00 K(0.0%) |
| Mar 1994 | - | -$200.00 K(-200.0%) | $100.00 K(-66.7%) |
| Dec 1993 | - | $200.00 K(+100.0%) | $300.00 K(+200.0%) |
| Sept 1993 | - | $100.00 K | $100.00 K |
FAQ
- What is Moderna annual cash flow from operations?
- What is the all time high annual CFO for Moderna?
- What is Moderna annual CFO year-on-year change?
- What is Moderna quarterly cash flow from operations?
- What is the all time high quarterly CFO for Moderna?
- What is Moderna quarterly CFO year-on-year change?
- What is Moderna TTM cash flow from operations?
- What is the all time high TTM CFO for Moderna?
- What is Moderna TTM CFO year-on-year change?
What is Moderna annual cash flow from operations?
The current annual CFO of MRNA is -$3.12 B
What is the all time high annual CFO for Moderna?
Moderna all-time high annual cash flow from operations is $13.62 B
What is Moderna annual CFO year-on-year change?
Over the past year, MRNA annual cash flow from operations has changed by -$8.10 B (-162.60%)
What is Moderna quarterly cash flow from operations?
The current quarterly CFO of MRNA is -$1.57 B
What is the all time high quarterly CFO for Moderna?
Moderna all-time high quarterly cash flow from operations is $4.06 B
What is Moderna quarterly CFO year-on-year change?
Over the past year, MRNA quarterly cash flow from operations has changed by +$34.00 M (+2.12%)
What is Moderna TTM cash flow from operations?
The current TTM CFO of MRNA is -$3.21 B
What is the all time high TTM CFO for Moderna?
Moderna all-time high TTM cash flow from operations is $13.62 B
What is Moderna TTM CFO year-on-year change?
Over the past year, MRNA TTM cash flow from operations has changed by -$1.13 B (-54.33%)